Ireland
--:--IST
Priya Life Science Clinical trial register
Trackers› Clinical trials› Heidelberg
Clinical trial register · Australia

Clinical Trials in Heidelberg, 2026

Every study on the ClinicalTrials.gov registry that lists a site in Australia and is open, about to open, active-but-closed, or enrolling by invitation. Filter it, cite it, and take it away as a file.

Download CSV
Source: ClinicalTrials.gov, U.S. National Library of Medicine. Complete coverage — all 3378 matching records held by the registry are in this view. Synced 14 Nov 2026, 03:19 UTC
3378
Studies in scope
all four open statuses
1824
Recruiting now
open to new participants
781
Lead sponsors
across recruiting studies
Top sites
Melbourne 22 Parkville 17 Woolloongabba 13 Heidelberg 13 Camperdown 13

Trials with a site in Heidelberg

13 of 3378 studies
Download
Status
Study
Lead sponsor
Phase
Enrol
Sites in Australia
Start
Recruiting
Hoffmann-La Roche
Phase 3
1,600
Blacktown, Camperdown, Meadowbrook, Oaklands Park, Heidelberg, Melbourne
2026-03-23
Recruiting
Hoffmann-La Roche
Phase 3
2,000
Blacktown, St Leonards, Oaklands Park, Heidelberg, Melbourne
2026-03-16
Recruiting
Hoffmann-La Roche
Phase 2
360
Camperdown, Kogarah, New Lambton Heights, Box Hill, Heidelberg
2026-03-10
Active, closed
Hoffmann-La Roche
Phase 3
1,060
Camperdown, Kogarah, Macquarie Park, Bedford Park, Woodville, Box Hill, Heidelberg, Melbourne
2025-11-12
Recruiting
Hoffmann-La Roche
Phase 3
600
Darlinghurst, Liverpool, Waratah, Birtinya, Hobart, Clayton, Heidelberg, Melbourne
2025-10-24
Recruiting
Hoffmann-La Roche
Phase 3
80,000
Camperdown, Darlinghurst, Kogarah, Macquarie Park, Bedford Park, Woodville, Box Hill, Heidelberg
2025-07-02
Active, closed
Hoffmann-La Roche
Phase 1
34
Darlinghurst, Heidelberg
2024-09-16
Recruiting
A Study to Evaluate the Efficacy and Safety of Pegozafermin in Participants With Compensated Cirrhosis Due to MASH
NCT06419374Metabolic Dysfunction-Associated Steatohepatitis (MASH) / Nonalcoholic Steatohepatitis (NASH) With Compensated Cirrhosis
Hoffmann-La Roche
Phase 3
1,800
Adelaide, Fitzroy, Greenslopes, Heidelberg, Herston, Murdoch, Perth, South Brisbane
2024-05-24
Recruiting
A Study Evaluating the Efficacy and Safety of Pegozafermin in Participants With MASH and Fibrosis (ENLIGHTEN-Fibrosis)
NCT06318169Metabolic Dysfunction-Associated Steatotic Liver Disease (MASH) / Nonalcoholic Steatohepatitis (NASH) With Fibrosis
Hoffmann-La Roche
Phase 3
1,350
Brisbane, Herston, South Brisbane, Adelaide, Bedford Park, Clayton, Heidelberg, Perth
2024-03-13
Active, closed
Hoffmann-La Roche
Phase 3
985
Camperdown, Liverpool, New Lambton, Woolloongabba, Box Hill, Heidelberg, Parkville
2020-10-26
Active, closed
Hoffmann-La Roche
Phase 3
1,013
Camperdown, Heidelberg, Parkville
2019-08-12
Active, closed
Hoffmann-La Roche
Phase 2
534
Liverpool, Newcastle, Bedford Park, Heidelberg
2015-11-19
Rows per page Showing 1–13 of 13
1
Cite this view

Priya Life Science (2026). Clinical trial register: studies with an Australian investigative site, filtered. Derived from ClinicalTrials.gov. Retrieved 17 November 2026. https://priyalifescience.com/clinical-trials-australia/city/heidelberg

Query this register directly
GET /api/trials?country=in&status=recruiting&format=json Try it now →

About this register

This register is built from ClinicalTrials.gov, the trial registry run by the U.S. National Library of Medicine. It includes every study on the registry that lists at least one investigative site in Australia and is recruiting, not yet recruiting, active but no longer recruiting, or enrolling by invitation: 3,378 studies in total at the last sync on 14 Nov 2026, 03:19 UTC. The full list can be downloaded as CSV or queried as JSON through the register API.

This page shows the 13 of those studies with a site in Heidelberg that also match the filters currently applied.

How many clinical trials are recruiting in Heidelberg?

7 of the 13 studies on this page are recruiting new participants as of the 14 Nov 2026, 03:19 UTC sync. A further 0 have not yet opened recruitment, 6 are active but closed to new participants, and 0 are enrolling by invitation only. Eligibility for any study is decided by its study team.

Summary by phase

Studies by phase (Heidelberg), 13 studies
PhaseStudiesRecruitingShare
Phase 310676.9%
Phase 22115.4%
Phase 1107.7%

Most active sponsors

Lead sponsors with the most studies (Heidelberg)
Lead sponsorStudiesRecruiting
Hoffmann-La Roche137
Listing here is informational and not medical advice; eligibility is determined by each study team. See also the Ireland, UK, EU, USA and China registers.